SRS4181631
SAMN10625680
GSM3526746
C4-2 cells_vehicle control for GSK126 and astemizole
9606
Homo sapiens
bioproject
511443
source_name
human prostatic carcinoma cell line
cell line
prostate cancer LNCaP-derived C4-2 cells
treatment
vehicle control for GSK126 and astemizole
passages
10-15
SRS4181634
SAMN10625679
GSM3526747
C4-2 cells_GSK126
9606
Homo sapiens
bioproject
511443
source_name
human prostatic carcinoma cell line
cell line
prostate cancer LNCaP-derived C4-2 cells
treatment
GSK126
passages
10-15
SRS4181635
SAMN10625678
GSM3526748
C4-2 cells_astemizole
9606
Homo sapiens
bioproject
511443
source_name
human prostatic carcinoma cell line
cell line
prostate cancer LNCaP-derived C4-2 cells
treatment
astemizole
passages
10-15
SRS4181636
SAMN10625677
GSM3526749
C4-2 cells_shRNA control for EZH2 knockdown
9606
Homo sapiens
bioproject
511443
source_name
human prostatic carcinoma cell line
cell line
prostate cancer LNCaP-derived C4-2 cells
treatment
shRNA control for EZH2 knockdown
passages
10-15
SRS4181637
SAMN10625676
GSM3526750
C4-2 cells_EZH2 shRNA #1
9606
Homo sapiens
bioproject
511443
source_name
human prostatic carcinoma cell line
cell line
prostate cancer LNCaP-derived C4-2 cells
treatment
EZH2 shRNA #1
passages
10-15
SRS4181638
SAMN10625675
GSM3526751
C4-2 cells_EZH2 shRNA #2
9606
Homo sapiens
bioproject
511443
source_name
human prostatic carcinoma cell line
cell line
prostate cancer LNCaP-derived C4-2 cells
treatment
EZH2 shRNA #2
passages
10-15